Public Joint Stock Company OTCPharm produces, markets, and sells pharmaceutical products in Russia. It offers OTC drugs comprising anti-aggregate agents, antiviral and immunomodulating drugs, preparations for the treatment of nervous system and gastrointestinal tract, drugs for SARS and influenza, analgesic and non-steroidal anti-inflammatory drugs, antifungal means, drugs used in obstetrics and gynecology, dermatotropin preparations, biologically active additives, venotonizing and angioprotective agents, and preparations containing vitamins, minerals, and plant antioxidants. The company also provides antiulcer, antiseptic, intestinal and astringents; and daily hygiene, prevention, and treatment products for inflammatory diseases of the nasal cavity, paranasal sinuses, and nasopharynx. It offers its products under the ARBIDOL, AMIXIN, AFOBAZOL, NOOPEPT, ACYPOL, LACTAZAR, CODELAC, MAXICOLD, RINOSTOP, COMPLIIT, SELMEVIT, MAGNELIS B6, LACTONORM, NEXT, PENTALGIN, FLUKOSTAT, CYCLOVITA, ZINOCAP, and other brands. The company is based in Moscow, Russia. Public Joint Stock Company OTCPharm is a subsidiary of MKOOO Augment Investments Limited.